J Korean Med Assoc.  2014 Jan;57(1):34-40. 10.5124/jkma.2014.57.1.34.

Diagnosis and treatment of extrapulmonary tuberculosis

• Kim SH

• KMID: 2194832
• DOI: http://doi.org/10.5124/jkma.2014.57.1.34

Abstract

Diagnosing extrapulmonary tuberculosis (E-TB) remains a challenge because clinical samples obtained from sites that are not easily accessible are sometimes paucibacillary, decreasing the sensitivity of diagnostic tests. Adenosine deaminase (ADA) is widely used for adjunct diagnosis of E-TB with extrasanguinous fluid. However, ADA is not a specific marker for E-TB, so a more specific test is urgently needed for the confirmation of E-TB. Recently, an IFN-gamma releasing assay using peripheral blood mononuclear cells and extrasanguinous fluid mononuclear cells, and the newly-developed Xpert MTB/RFP have shown promising results for the rapid diagnosis of E-TB. Although the regimen of antituberculous medication for E-TB is similar to that for pulmonary tuberculosis, the treatment of E-TB is occasionally complicated due to a paradoxical response during antituberculous therapy and after the completion of antituberculous therapy, especially in tuberculous lymphadenopathy. The proposed algorithm for the management of paradoxical response in tuberculous lymphadenopathy is presented, and the treatment for E-TB in various sites is briefly reviewed.

Keyword

Tuberculosis; Diagnosis; Therapeutics

MeSH Terms

Adenosine Deaminase
Diagnosis*
Diagnostic Tests, Routine
Lymphatic Diseases
Tuberculosis*
Tuberculosis, Pulmonary
Adenosine Deaminase

Figure

• 

  Figure 1 Time distribution of paradoxical response in tuberculous lymphadenopathy.

• 

  Figure 2 Proposed management of paradoxical response in tuberculous (TB) lymphadenopahty. (A) During antituberculous therapy. (B) After completion of antituberculous therapy.

Reference

1. Schlossberg D. Tuberculosis and nontuberculous mycobacterial infections. 6th ed. Washington, DC: ASM Press;2011.

2. Asghar RJ, Pratt RH, Kammerer JS, Navin TR. Tuberculosis in South Asians living in the United States, 1993-2004. Arch Intern Med. 2008; 168:936–942.

3. Korea Centers for Disease Control and Prevention. 2012 Annual report on the notified tuberculosis patients in Korea [Internet]. Seoul: Bokjiro;2013. cited 2013 Dec 26. Available from: http://www.bokjiro.go.kr/data/statusView.do?board_sid=297&data_sid=6090680.

4. Kim SH, Choi SJ, Kim HB, Kim NJ, Oh MD, Choe KW. Diagnostic usefulness of a T-cell based assay for extra-pulmonary tuberculosis. Arch Intern Med. 2007; 167:2255–2259.

5. Cho OH, Park KH, Kim T, Song EH, Jang EY, Lee EJ, Chong YP, Choi SH, Lee SO, Woo JH, Kim YS, Kim SH. Paradoxical responses in non-HIV-infected patients with peripheral lymph node tuberculosis. J Infect. 2009; 59:56–61.

6. Peto HM, Pratt RH, Harrington TA, LoBue PA, Armstrong LR. Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. Clin Infect Dis. 2009; 49:1350–1357.

7. Yang H, Field SK, Fisher DA, Cowie RL. Tuberculosis in Calgary, Canada, 1995-2002: site of disease and drug susceptibility. Int J Tuberc Lung Dis. 2005; 9:288–293.

8. Cho OH, Park KH, Park SY, Moon SM, Chong YP, Kim MN, Lee SO, Choi SH, Woo JH, Kim YS, Kim SH. Drug-resistant extrapulmonary tuberculosis. Infect Chemother. 2011; 43:258–261.

9. Rock RB, Olin M, Baker CA, Molitor TW, Peterson PK. Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev. 2008; 21:243–261.

10. Greco S, Girardi E, Masciangelo R, Capoccetta GB, Saltini C. Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: a meta-analysis. Int J Tuberc Lung Dis. 2003; 7:777–786.

11. Riquelme A, Calvo M, Salech F, Valderrama S, Pattillo A, Arellano M, Arrese M, Soza A, Viviani P, Letelier LM. Value of adenosine deaminase (ADA) in ascitic fluid for the diagnosis of tuberculous peritonitis: a meta-analysis. J Clin Gastroenterol. 2006; 40:705–710.

12. Liao YJ, Wu CY, Lee SW, Lee CL, Yang SS, Chang CS, Lee TY. Adenosine deaminase activity in tuberculous peritonitis among patients with underlying liver cirrhosis. World J Gastroenterol. 2012; 18:5260–5265.

13. Tuon FF, Litvoc MN, Lopes MI. Adenosine deaminase and tuberculous pericarditis: a systematic review with meta-analysis. Acta Trop. 2006; 99:67–74.

14. Fan L, Chen Z, Hao XH, Hu ZY, Xiao HP. Interferon-gamma release assays for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. FEMS Immunol Med Microbiol. 2012; 65:456–466.

15. Cho OH, Park KH, Kim SM, Park SJ, Moon SM, Chong YP, Sung H, Kim MN, Jeong JY, Lee SO, Choi SH, Woo JH, Kim YS, Kim SH. Diagnostic performance of T-SPOT.TB for extrapulmonary tuberculosis according to the site of infection. J Infect. 2011; 63:362–369.

16. Lee YM, Park KH, Kim SM, Park SJ, Lee SO, Choi SH, Kim YS, Woo JH, Kim SH. Diagnostic usefulness of a T-cell-based assay in patients with miliary tuberculosis compared with those with lymph node tuberculosis. Clin Infect Dis. 2013; 56:e26–e29.

17. Kim SH, Cho OH, Park SJ, Lee EM, Kim MN, Lee SO, Choi SH, Kim YS, Woo JH, Lee SA, Kang JK. Rapid diagnosis of tuberculous meningitis by T cell-based assays on peripheral blood and cerebrospinal fluid mononuclear cells. Clin Infect Dis. 2010; 50:1349–1358.

18. Tortoli E, Russo C, Piersimoni C, Mazzola E, Dal Monte P, Pascarella M, Borroni E, Mondo A, Piana F, Scarparo C, Coltella L, Lombardi G, Cirillo DM. Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur Respir J. 2012; 40:442–447.

19. Park KH, Lee MS, Lee SO, Choi SH, Kim YS, Woo JH, Kim SH. Incidence and outcomes of paradoxical lymph node enlargement after anti-tuberculosis therapy in non-HIV patients. J Infect. 2013; 67:408–415.

20. Van Loenhout-Rooyackers JH, Keyser A, Laheij RJ, Verbeek AL, van der Meer JW. Tuberculous meningitis: is a 6-month treatment regimen sufficient? Int J Tuberc Lung Dis. 2001; 5:1028–1035.

21. Thwaites GE, Nguyen DB, Nguyen HD, Hoang TQ, Do TT, Nguyen TC, Nguyen QH, Nguyen TT, Nguyen NH, Nguyen TN, Nguyen NL, Nguyen HD, Vu NT, Cao HH, Tran TH, Pham PM, Nguyen TD, Stepniewska K, White NJ, Tran TH, Farrar JJ. Dexamethasone for the treatment of tubercu-lous meningitis in adolescents and adults. N Engl J Med. 2004; 351:1741–1751.

22. Engel ME, Matchaba PT, Volmink J. Corticosteroids for tuberculous pleurisy. Cochrane Database Syst Rev. 2007; (4):CD001876.

23. Haas DW. Is adjunctive corticosteroid therapy indicated during tuberculous peritonitis? Clin Infect Dis. 1998; 27:57–58.

24. Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation. 2005; 112:3608–3616.